Skip to main content
. 2011 May 13;18(7):489–499. doi: 10.1038/cgt.2011.18

Figure 4.

Figure 4

AdVova stimulates preventive ovalbumin (OVA)-specific antitumor immunity in wild-type C57BL/6 mice. (a) AdVova-immunized C57BL/6 mice were s.c. challenged with BL6-10ova tumor cells on day 11 after the immunization. One day before tumor challenge, mice were i.p. injected with anti-CD8 or anti-NK1.1 antibody (0.3 mg per mouse). The antibody treatment was repeated once every 3 days for a total of five times. (b) AdVova-immunized C57BL/6 mice were s.c. challenged with BL6-10ova tumor cells on day 60 after the immunization. Tumor growth was monitored. One representative experiment of two is shown. AdV, adenovirus; NK, natural killer.